This review has identified that SPS constitute a critical resource for patient safety, medicines optimisation and the delivery of cost-effective care, and the provision of specialist advice, particularly in the context of complex issues involving medicines.
The following key recommendations have been made:
• There should be a single NHS SPS, which is deployed regionally and more locally to provide equitable access to specialist pharmaceutical expertise.
• The SPS should be directly commissioned by NHS England against a national specification, which provides clarity to both service users and SPS providers on access, functions, levels of service and performance.
• An SPS National Management Board and Implementation Group should be established
• Deployment in relation to the national specification from 2014-15 should be delivered within an agreed overall cost envelope.